FindTrial
Sign In

Effect of Xenon, in Combination with Therapeutic Hypothermia, on the Brain and on Neurological Outcome following Brain Ischemia in Cardiac Arrest Patients

Effect of Xenon, in Combination with Therapeutic Hypothermia, on the Brain and on Neurological Outcome following Brain Ischemia in Cardiac Arrest Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-009505-25-FI
Enrollment
Unknown
Registered
2009-02-17
Start date
2009-03-18
Completion date
Unknown
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sydänpysähdyksen jälkeinen globaali iskemia MedDRA version: 9.1 Level: LLT Classification code 10054438 Term: Ischemia MedDRA version: 9.1 Level: LLT Classification code 10007515 Term: Cardiac arrest

Interventions

Trade Name: LENOXe Product Name: LENOXe Pharmaceutical Form: Inhalation gas INN or Proposed INN: XENON (133 XE) CAS Number: 14932424

Sponsors

Timo Laitio
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026